Skip to main content
. 2018 Oct 31;8:16111. doi: 10.1038/s41598-018-34553-x

Figure 3.

Figure 3

(A) A bar chart shows the clinical effects of sodium oxybate in drug-nonresponders and drug-responders, which were assessed based on perceptual analysis of voice symptoms at a baseline and following sodium oxybate treatment. (B) A series of axial brain slices show regions of common (in purple) and distinct (in green) action of sodium oxybate in drug-responders and non-responders at FWE-corrected p ≤ 0.05.